1,204 results on '"Ahn, Sei"'
Search Results
152. Clinical features and course of brain metastases in triple-negative breast cancer: comparison with human epidermal growth factor receptor 2-positive and other type at single institution in Korea
153. Impact of Omission of Axillary Lymph Node Dissection After Negative Sentinel Lymph Node Biopsy: 70-Month Follow-up
154. Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis
155. PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations
156. Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy
157. Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer
158. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: A nationwide retrospective study
159. Heterogeneity of epidemiological factors by breast tumor subtypes in Korean women: A case–case study
160. Correlates of existential well-being and their association with health-related quality of life in breast cancer survivors compared with the general population
161. Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them
162. Axillary recurrence after negative sentinel lymph node biopsy
163. The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation
164. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk
165. Sentinel node biopsy in patients with multiple breast cancer
166. Tumor-to-Nipple Distance and the Safety of Nipple-Sparing Mastectomy
167. Risk of Endometrial Cancer and Frequencies of Invasive Endometrial Procedures in Young Breast Cancer Survivors Treated With Tamoxifen: A Nationwide Study
168. Prognosis according to clinical and pathologic lymph node status in breast cancer patients who underwent sentinel lymph node biopsy alone after neoadjuvant therapy
169. A Propensity Score-matched Analysis of Long-term Oncologic Outcomes After Nipple-sparing Versus Conventional Mastectomy for Locally Advanced Breast Cancer.
170. Effectiveness of a 6-Month 22.5-mg Leuprolide Acetate Depot Formulation With Tamoxifen for Postoperative Premenopausal Estrogen Suppression in Hormone Receptor-Positive Breast Cancer
171. Data on distant metastasis and survival after locoregional recurrence following nipple-sparing mastectomy and immediate breast reconstruction
172. Genetic polymorphisms of NOS3 are associated with the risk of invasive breast cancer with lymph node involvement
173. Do Very Young Korean Breast Cancer Patients Have Worse Outcomes?
174. Genome-wide association study identifies novel breast cancer susceptibility loci
175. Genetic polymorphism of XRCC3 Thr241Met and breast cancer risk: case-control study in Korean women and meta-analysis of 12 studies
176. Additional file 1 of Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer
177. Genetic Polymorphisms of eNOS, Hormone Receptor Status, and Survival of Breast Cancer
178. Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996–2004
179. Treatment-induced menstrual changes in very young (<35 years old) breast cancer patients
180. Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women
181. Clinical implication of subcategorizing T2 category into T2a and T2b in TNM staging of breast cancer
182. BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations
183. Korean translation and validation of the functional assessment of cancer therapy-breast (FACT-B) scale version 4
184. Genetic polymorphisms of TGF-β1 & TNF-β and breast cancer risk
185. Comparison of Survival Outcomes for Axillary Surgery Extent Based on Intraoperative Sentinel Lymph Node Biopsy Result After Neoadjuvant Chemotherapy for Breast Cancer
186. Is there a difference in the diagnosis and prognosis of local recurrence between autologous tissue and implant-based breast reconstruction?
187. Abstract PS13-07: Neoadjuvant adriamycin plus cyclophosphamide followed by docetaxel (AC4-D4) vs 5-fluorouracil, epirubicin plus cyclophosphamide followed by docetaxel (FEC3-D3) in stage II or III operable breast cancer : Randomized phase III neo-shorter trial (NCT02001506)
188. Abstract PD12-07: Incidences of endometrial events and frequencies of endometrial invasive diagnostic procedures in breast cancer survivors on tamoxifen: A nationwide study
189. Clinical Outcomes Following Letrozole Treatment according to Estrogen Receptor Expression in Postmenopausal Women: LETTER Study (KBCSG-006)
190. Combined effect of GSTM1, GSTT1, and COMT genotypes in individual
191. The meaning of the c-kit proto-oncogene product in malignant transformation in human mammary epithelium
192. 18F-fluorodeoxyglucose uptake predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: A retrospective cohort study
193. p16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy
194. Association between tumor 18F-fluorodeoxyglucose metabolism and survival in women with estrogen receptor-positive, HER2-negative breast cancer.
195. Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling
196. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium†
197. Updated Longitudinal Data on Acute Exacerbation of Chronic Hepatitis B in Patients With Breast Cancer Receiving Anthracycline-based Adjuvant Chemotherapy: Therapeutic vs. Pre-emptive Use of Lamivudine
198. Development and Validation of a Next-Generation Sequencing–Based Multigene Assay to Predict the Prognosis of Estrogen Receptor–Positive, HER2-Negative Breast Cancer
199. Long-term Oncologic Outcomes of Immediate Breast Reconstruction vs Conventional Mastectomy Alone for Breast Cancer in the Setting of Neoadjuvant Chemotherapy
200. A Propensity Score-matched Analysis of Long-term Oncologic Outcomes After Nipple-sparing Versus Conventional Mastectomy for Locally Advanced Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.